MeSH tree: D12.776.543.750.695
Chronic alcohol consumption profoundly alters gene expression in key brain regions involved in reward, impulse control, and decision-making, according to a study led by researchers at the Institute for Neurosciences, a joint ...
Feb 9, 2026
0
41
GLP-1 drugs have ushered in a new era in weight loss.
Feb 7, 2026
0
25
The public debate on cannabis is dominated by a tone of normalization—less stigmatization, more freedom of choice. The promise of a "natural" alternative to medicines. Meanwhile, science, although still incomplete, is painting ...
Feb 5, 2026
0
34
Research studying the effects of cannabis on the brain has often focused on adolescents, but a new study from CU Anschutz researchers looks at population-level impacts of cannabis usage on the brain in older adults. The work ...
Feb 3, 2026
4
8607
In the world of obesity research, the arrival of GLP-1 drugs like Ozempic feels seismic. At a recent conference, Martin Binks, a leader in obesity research, found himself marveling with a colleague: "Can you believe we finally ...
Feb 3, 2026
0
12
Researchers at University of Tsukuba and their collaborators have demonstrated that learning from both rewarding and aversive outcomes requires a common brain molecule, sulfatase 1 (Sulf1). This extracellular enzyme removes ...
Jan 28, 2026
0
7
A new study led by Mayo Clinic found that postmenopausal women receiving menopausal hormone therapy lost 35% more weight while taking tirzepatide, a Food and Drug Administration-approved drug for the treatment of overweight ...
Jan 23, 2026
0
16
With more studies emerging, GLP-1 and dual GIP/GLP-1 medications have become well-established options for those with obesity or type 2 diabetes.
Jan 22, 2026
0
15
Alcohol use is widespread and alcohol use disorder (AUD) causes substantial harm. AUD affects 29 million individuals and causes more than 140,000 deaths annually in the U.S. alone. Individuals with AUD also often struggle ...
Jan 17, 2026
0
60
Federal health regulators say popular weight loss drugs like Wegovy and Zepbound do not increase the risk of suicidal thoughts, and they have asked drugmakers to remove those warnings from medication labels.
Jan 15, 2026
0
12
